Tag: Crohn’s Disease treatment
Long-Term Hope: Vedolizumab Proves Safe for Extended IBD Treatment
New long-term safety data for Vedolizumab shows encouraging results for IBD patients, with low rates of serious side effects even after years of use. This evidence provides much-needed reassurance for those considering or currently using this targeted biologic therapy.
New Hope for Severe Crohn’s: Breakthrough Drug Targets Scarring
Agomab Therapeutics has launched a groundbreaking clinical trial for ontunisertib, a drug specifically targeting fibrostenosing Crohn’s disease—the severe, scarring form that has limited treatment options. This represents the first targeted therapy designed to address the root cause of intestinal scarring rather than just managing symptoms.
The FMT Study That Didn’t Work: What It Teaches Us About Crohn’s
A recent study tested fecal microbiota transplantation (FMT) for Crohn’s disease with disappointing results—but what can we learn from this setback? While FMT didn’t improve remission rates in 8 weeks, the research offers valuable insights for future treatments and reminds us that progress in IBD research often comes through understanding what doesn’t work.
Scientists Uncover Why Fistulas Form—Hope for Crohn’s Patients
New research from University Hospital of Zürich reveals how specific cells called fibroblasts contribute to fistula formation in Crohn’s disease. This breakthrough could lead to targeted treatments that prevent or treat one of IBD’s most challenging complications.
Asia-Pacific’s IBD Crisis: Why Early Action Could Change Everything
Asia-Pacific countries are developing new strategies to tackle rising IBD rates through early intervention and comprehensive care. This shift could transform outcomes for millions living with Crohn’s disease and ulcerative colitis in the region.
World-First Surgery Gives Hope to Pregnant IBD Patients
Israeli surgeons achieved a world-first by performing robotic surgery on a pregnant Crohn’s patient, saving both mother and baby. This breakthrough offers new hope for IBD patients facing pregnancy complications.
Early Crohn’s Treatment Could Transform Your Disease Journey
New research from the LOVE-CD study reveals that starting biologic treatment within 18 months of Crohn’s diagnosis leads to significantly better outcomes than waiting. This could fundamentally change how we approach early IBD care.
Cannabis and Crohn’s: New Study Reveals Unexpected Risks
A new study examining over 4,000 Crohn’s patients reveals that cannabis users experienced higher rates of hospitalizations, surgeries, and disease flares. While cannabis may provide symptom relief, researchers suggest it could mask underlying disease progression, raising important questions about balancing short-term comfort with long-term health outcomes.
New Guidelines Bring Hope to Families Managing Pediatric Crohn’s
New clinical practice guidelines from the Canadian Association of Gastroenterology offer hope for families managing pediatric Crohn’s disease. These evidence-based recommendations provide a clearer roadmap for personalized treatment approaches that prioritize both effective care and quality of life for children with IBD.
Crohn’s Surgery After 60: What New Research Reveals
New European research reveals that older adults with Crohn’s disease actually experience fewer immediate surgical complications than younger patients, challenging common assumptions about age and surgery risk. While long-term considerations remain important, this data offers hope for those over 60 facing difficult treatment decisions.
